What are the evidence‑based recommendations for managing arthritis pain, including non‑pharmacologic measures, topical and oral therapies, and when to consider advanced treatments?

Arthritis Pain Management: Evidence-Based Recommendations

Core Non-Pharmacologic Treatments (Foundation for All Patients)

All patients with arthritis should receive education, structured exercise programs, and weight management as the cornerstone of treatment before or alongside any pharmacologic intervention. 1

• Education and self-management: Provide written and oral information to counter the misconception that arthritis is inevitably progressive and untreatable, with reinforcement at each clinical encounter. 1

• Structured exercise programs: Prescribe joint-specific strengthening exercises combined with general aerobic fitness training (land-based or aquatic), with adequate dosage and progression tailored to physical function. Effect sizes for pain reduction range from 0.57 to 1.0. 1

• Weight loss: For overweight or obese patients (BMI ≥25 kg/m²), implement interventions to achieve and maintain weight loss, which significantly reduces arthritis symptoms and disease progression. 1

Pharmacologic Treatment Algorithm for Osteoarthritis

First-Line: Acetaminophen (Paracetamol)

Start with acetaminophen 3,000–4,000 mg daily in divided doses as the initial pharmacologic treatment for osteoarthritis pain. 1

• Acetaminophen provides pain relief comparable to NSAIDs in many patients with mild-to-moderate disease, with a significantly safer profile, particularly in elderly patients. 1, 2
• Regular scheduled dosing throughout the day provides better sustained pain control than "as needed" dosing. 1, 2
• Consider a 3,000 mg daily maximum in elderly patients to minimize hepatotoxicity risk. 2

Second-Line: Topical NSAIDs

If acetaminophen alone is insufficient, add topical NSAIDs (diclofenac or ketoprofen gel) to the affected joint before considering oral NSAIDs. 1

• Topical NSAIDs demonstrate statistically significant effects on pain, stiffness, and function with minimal systemic absorption, avoiding gastrointestinal, renal, and cardiovascular risks. 1, 2
• Particularly appropriate for knee and hand osteoarthritis. 1

Third-Line: Oral NSAIDs or COX-2 Inhibitors

Use oral NSAIDs or COX-2 inhibitors only after topical agents have failed, at the lowest effective dose for the shortest possible duration, and always co-prescribe with a proton pump inhibitor for gastroprotection. 1

• All oral NSAIDs and COX-2 inhibitors have similar analgesic efficacy but vary in gastrointestinal, liver, renal, and cardiovascular toxicity. 1
• Assess cardiovascular, gastrointestinal, and renal risk factors before prescribing, particularly in patients over 65 years. 1
• Contraindicated or require extreme caution in patients with renal insufficiency, heart failure, hypertension, or cardiovascular disease. 1
• NSAIDs should be used at the minimum effective dose for the shortest time possible after evaluation of risks. 1

Fourth-Line: Duloxetine (for neuropathic component)

Consider duloxetine 30 mg daily for one week, then titrated to 60 mg daily, for osteoarthritis pain with a neuropathic component or when other treatments have failed. 1

• Duloxetine achieves significant reductions in pain and improvements in physical function for patients with osteoarthritis. 1
• Must be taken daily (not as needed) and tapered over at least 2–4 weeks when discontinuing after more than 3 weeks of therapy. 1

Intra-Articular Corticosteroid Injections

For moderate-to-severe pain with joint effusion, administer intra-articular corticosteroid injection for short-term relief (1–3 weeks). 1

• Particularly effective for acute flares of knee or hip osteoarthritis accompanied by effusion. 1
• Strongly recommended for elderly patients who cannot tolerate oral NSAIDs. 1

Adjunctive Non-Pharmacologic Interventions

• Local heat or cold applications: Apply before exercise or during pain flares for temporary relief. 1
• Manual therapy: Consider manipulation and stretching, particularly for hip osteoarthritis. 1
• Assistive devices: Provide walking aids, shock-absorbing footwear, and adaptive equipment for activities of daily living. 1
• Bracing and supports: Assess for knee braces, joint supports, or insoles in patients with biomechanical joint pain or instability. 1
• TENS (transcutaneous electrical nerve stimulation): May be considered as an adjunct. 1

Inflammatory Arthritis (Rheumatoid Arthritis, Spondyloarthritis)

Disease-Modifying Treatment

For inflammatory arthritis, methotrexate should be the anchor drug and part of the first treatment strategy unless contraindicated, with the goal of achieving clinical remission. 1

• Start DMARDs as early as possible (ideally within 3 months) in patients at risk of persistent disease. 1
• Monitor disease activity every 1–3 months using composite measures (tender/swollen joint counts, patient/physician global assessments, ESR/CRP) until treatment target is reached. 1

Symptomatic Pain Management

NSAIDs are effective symptomatic therapies but should be used at the minimum effective dose for the shortest time possible after evaluation of gastrointestinal, renal, and cardiovascular risks. 1

• Systemic glucocorticoids reduce pain, swelling, and structural progression but should be used at the lowest dose necessary as temporary (<6 months) adjunctive treatment due to cumulative side effects. 1
• Intra-articular glucocorticoid injections should be considered for relief of local symptoms of inflammation. 1

Non-Pharmacologic Adjuncts

Dynamic exercises and occupational therapy should be considered as adjuncts to drug treatment in patients with inflammatory arthritis. 1

• Smoking cessation, dental care, weight control, vaccination status assessment, and comorbidity management should be part of overall patient care. 1

Treatments NOT Recommended

The following treatments should NOT be used for arthritis pain management:

• Glucosamine and chondroitin products: Not recommended based on current evidence. 1
• Opioids (including tramadol): Strongly not recommended due to limited benefit, high risk of adverse effects, withdrawal symptoms, and serious adverse events. 1, 3
• Electroacupuncture: Should not be used. 1
• Hyaluronic acid injections (hip): Consistently recommended against. 4

Advanced Treatment Considerations

Referral for Surgery

Consider referral for joint arthroplasty when:

• Pain or functional limitation persists despite optimal non-pharmacologic and pharmacologic management. 1
• The patient has moderate-to-severe symptomatic osteoarthritis with radiographic evidence and has failed medical therapy. 1
• Do not delay arthroplasty for additional nonoperative treatment (physical therapy, NSAIDs, injections) once the decision for surgery is appropriate. 1

Special Populations

For elderly patients:

• Prioritize acetaminophen and topical NSAIDs over oral NSAIDs due to markedly higher risks of gastrointestinal bleeding, renal impairment, and cardiovascular events. 1, 2
• Assess renal function before initiating any oral NSAID. 1, 2

For patients with cardiovascular comorbidities:

• Avoid oral NSAIDs entirely; use is not recommended. 3

For patients with gastrointestinal comorbidities:

• If oral NSAIDs are necessary, use COX-2 inhibitors with mandatory proton pump inhibitor co-prescription. 1, 2

Critical Safety Pitfalls to Avoid

• Never prescribe oral NSAIDs without concurrent gastroprotective therapy (proton pump inhibitor). 1
• Never combine acetaminophen with oral NSAIDs as initial therapy. 1
• Never exceed 4,000 mg daily of acetaminophen (3,000 mg in elderly). 1, 2
• Never use opioids as routine treatment for osteoarthritis pain. 1, 3
• Never delay DMARD initiation in inflammatory arthritis; start within 3 months of symptom onset. 1